Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Variant pubertal development in Prader-Willi syndrome: early and slow progression of pubarche with normal age at gonadarche

A. Kodytková, P. Dušátková, SA. Amaratunga, S. Koloušková, B. Obermannová, R. Pomahačová, Š. Průhová, M. Šnajderová, Z. Šumník, J. Zapletalová, V. Semjonov, J. Lebl

. 2025 ; 16 (-) : 1527140. [pub] 20250415

Language English Country Switzerland

Document type Journal Article

INTRODUCTION: Prader-Willi syndrome (PWS) is primarily caused by a paternal microdeletion of the 15q11-q13 region, maternal uniparental disomy (mUPD) or unbalanced translocations. The MKRN3 gene, located within 15q11-q13, is a master regulator of pubertal initiation. We aimed to compare variant pubertal onset and progression with recent normative data and to correlate it with abnormal MKRN3 gene status. METHODS: Age at pubarche, gonadarche, subsequent pubertal progression and bone age (BA) at gonadarche were investigated in 37 PWS patients (18 females) who already entered pubarche and/or gonadarche with median age 11.1 (95% CI: 6.4 - 18.8) years. All patients were re-tested to confirm genetic subtypes of PWS. The MKRN3 gene was analyzed using single gene sequencing. RESULTS: Out of 37 subjects, 22 had microdeletion and 15 mUPD. Regardless of genetic subtypes and MKRN3 gene status, no correlation between genotypes and the pubertal pattern was found. They initiated pubarche early - girls at 7.4 (95%CI:6.4-8.4), and boys at 9.2 (8.2-10.2) years. The subsequent progression from PH2 to PH4 (pubic hair development) was prolonged to 3.7 years in girls (1.5-5.9;p<0.05), and 2.9 in boys (2.2-3.6;p<0.001). The age at gonadarche was adequate - 10.0 years in girls (8.8-11.2), and 11.0 in boys (9.8-12.1). Progression rate of breast development from B2 to B4 was 3.9 (0.2-7.5) years in girls and of testicular volume from 4 ml to 15ml was 3.8 (0.0-8.1) years in boys. The BA at gonadarche is advanced by 0.6 ± 1.1 years (p<0.001). CONCLUSIONS: Children with PWS, regardless of the genetic subtype and/or MKRN3 status, had an early pubarche and normally timed gonadarche. Pubarche progression was slower. Advanced BA was significantly correlated with gonadarche.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016096
003      
CZ-PrNML
005      
20250731091522.0
007      
ta
008      
250708e20250415sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2025.1527140 $2 doi
035    __
$a (PubMed)40303632
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kodytková, Aneta $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
245    10
$a Variant pubertal development in Prader-Willi syndrome: early and slow progression of pubarche with normal age at gonadarche / $c A. Kodytková, P. Dušátková, SA. Amaratunga, S. Koloušková, B. Obermannová, R. Pomahačová, Š. Průhová, M. Šnajderová, Z. Šumník, J. Zapletalová, V. Semjonov, J. Lebl
520    9_
$a INTRODUCTION: Prader-Willi syndrome (PWS) is primarily caused by a paternal microdeletion of the 15q11-q13 region, maternal uniparental disomy (mUPD) or unbalanced translocations. The MKRN3 gene, located within 15q11-q13, is a master regulator of pubertal initiation. We aimed to compare variant pubertal onset and progression with recent normative data and to correlate it with abnormal MKRN3 gene status. METHODS: Age at pubarche, gonadarche, subsequent pubertal progression and bone age (BA) at gonadarche were investigated in 37 PWS patients (18 females) who already entered pubarche and/or gonadarche with median age 11.1 (95% CI: 6.4 - 18.8) years. All patients were re-tested to confirm genetic subtypes of PWS. The MKRN3 gene was analyzed using single gene sequencing. RESULTS: Out of 37 subjects, 22 had microdeletion and 15 mUPD. Regardless of genetic subtypes and MKRN3 gene status, no correlation between genotypes and the pubertal pattern was found. They initiated pubarche early - girls at 7.4 (95%CI:6.4-8.4), and boys at 9.2 (8.2-10.2) years. The subsequent progression from PH2 to PH4 (pubic hair development) was prolonged to 3.7 years in girls (1.5-5.9;p<0.05), and 2.9 in boys (2.2-3.6;p<0.001). The age at gonadarche was adequate - 10.0 years in girls (8.8-11.2), and 11.0 in boys (9.8-12.1). Progression rate of breast development from B2 to B4 was 3.9 (0.2-7.5) years in girls and of testicular volume from 4 ml to 15ml was 3.8 (0.0-8.1) years in boys. The BA at gonadarche is advanced by 0.6 ± 1.1 years (p<0.001). CONCLUSIONS: Children with PWS, regardless of the genetic subtype and/or MKRN3 status, had an early pubarche and normally timed gonadarche. Pubarche progression was slower. Advanced BA was significantly correlated with gonadarche.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a Praderův-Williho syndrom $x genetika $x patofyziologie $7 D011218
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    12
$a puberta $x fyziologie $x genetika $7 D011627
650    _2
$a ubikvitinligasy $x genetika $7 D044767
650    _2
$a ribonukleoproteiny $x genetika $7 D012261
650    _2
$a progrese nemoci $7 D018450
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dušátková, Petra $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Amaratunga, Shenali Anne $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Koloušková, Stanislava $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Obermannová, Barbora $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Pomahačová, Renata $u Department of Pediatrics, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czechia
700    1_
$a Průhová, Štěpánka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Šnajderová, Marta $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Šumník, Zdeněk $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Zapletalová, Jiřina $u Department of Pediatrics, Faculty of Medicine, Palacky University and Olomouc University Hospital, Olomouc, Czechia
700    1_
$a Semjonov, Valerij $u Department of Statistics, Motol University Hospital, Prague, Czechia
700    1_
$a Lebl, Jan $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 16 (20250415), s. 1527140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40303632 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091517 $b ABA008
999    __
$a ok $b bmc $g 2366740 $s 1253221
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 16 $c - $d 1527140 $e 20250415 $i 1664-2392 $m Frontiers in endocrinology $n Front Endocrinol (Lausanne) $x MED00174543
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...